Experts believe people in China will continue to experience various respiratory pathogens alternating or co-circulating in the winter and the coming spring, with influenza viruses still dominating in the short term, according to Global Times report. According to Wang Dayan, director of the China National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), due to continuous importation of the JN.1 variant strain, a gradual downward trend in domestic influenza, and a decline in population immunity, the COVID-19 epidemic might rebound in January, with the JN.1 variant highly likely to develop into the dominant variant in China.COVID infections may rebound in January, Chinese health authorities warn
GeneralExperts believe people in China will continue to experience various respiratory pathogens alternating or co-circulating in the winter and the coming spring, with influenza viruses still dominating in the short term, according to Global Times report. According to Wang Dayan, director of the China National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), due to continuous importation of the JN.1 variant strain, a gradual downward trend in domestic influenza, and a decline in population immunity, the COVID-19 epidemic might rebound in January, with the JN.1 variant highly likely to develop into the dominant variant in China.
Comments